Hemp Stock News: Hemp for Health Inc. (CSE: HFH) Receives Positive Analysis for Its Test Crop Carmagnola
Vancouver, British Columbia - December 17, 2019 (Newsfile Corp.) (Investorideas.com Newswire) HEMP FOR HEALTH INC. (CSE: HFH) (the "Company"), a cultivator and distributor of premium CBD products in Italy and Europe, is pleased to announce its lab results from its test crop of Carmagnola Hemp that was planted for the 2019 growing season.
The certificate of analysis was provided by an independent laboratory, Crabion Toxicology, in Italy. The results for the two varieties of Carmagnola came back favorably with 14% CBD and 0.03 THC and 4.7% CBD and 0.01% THC. The results are listed in the following tables:
"We are pleased with the results and cultivation of this year's test crop of Carmagnola Hemp," reported C.E.O. and founder, Robert Eadie. "The strain which is native to Italy and recognized by the EU as a low technical cultivator with low THC is positive for our future products and the end users."
Some other benefits and unique traits of the Carmagnola variety are displayed below in the diagram:
About Hemp for Health Inc.:
Hemp for Health is a cultivator and distributor of premium CBD products with an exclusive, long-term contract for land with farmers in the Tuscan region of Italy for the purpose of yielding the highest quality hemp-based CBD. Our focus is to offer the absolute best in natural and organic CBD products to our customers, and that starts with pristine soil, seeds, and sun. (See further details available in the Company's filings on SEDAR.)
ON BEHALF OF HEMP FOR HEALTH INC.
(sgd.) Robert Eadie
President & CEO
The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.
Top cannabis news story today on Investorideas.com
A CBD Holiday for Consumers - New Products and Retail Developments (OTCQB: $CANB) (CSE: $IAN.C) (TSX: $WEED.TO) (NYSE: $CGC) (OTC: $PURA)
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com